Epidemiology of varicella and effectiveness of varicella vaccine in Hangzhou, China, 2019

Background: The varicella vaccine (VarV) is not included in the national childhood immunization schedules in China, although 2-dose VarV (VarV2) were recommended for children at 1 and 4 years of age in Hangzhou since 2014. However, the reported incremental vaccine effectiveness (VE) of VarV2 varies...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Hum Vaccin Immunother
Auteurs principaux: Xu, Yuyang, Liu, Yan, Zhang, Xiaoping, Zhang, Xuechao, Du, Jian, Cai, Yuxin, Wang, Jun, Che, Xinren, Gu, Wenwen, Jiang, Wei, Chen, Junfang
Format: Artigo
Langue:Inglês
Publié: Taylor & Francis 2020
Sujets:
Research Paper
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC7872021/
https://ncbi.nlm.nih.gov/pubmed/32574100
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/21645515.2020.1769395
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires